Skip to main content

Bellevue Group AG

SEC CIK
0001674546
Latest filing
Aug 14, 2026

DMRA holding history

Damora Therapeutics, Inc. in every 13F filed by Bellevue Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DMRA overviewAll 13F holders of DMRAFull Q2 2026 holdings

Shares (Q2 2026)
1,618,846
Value
$42.1M
% of portfolio
0.9%
Quarters held
2
Since Q1 2026
Holdings of DMRA by Bellevue Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,618,846$42.1M0.9%−679,154−29.6%ReducedHolders
Q1 20262,298,000$59.5M1.4%+2,298,000NewHolders